Long-term remission after first-line single-agent treatment with arsenic trioxide of relapsed acute promyelocytic leukemia in an 8-year-old boy

Pediatric Hematology and Oncology

Volumn 28, Issue 4, 2011, Pages 334-337

  Ebinger, Martin ^a   Schwarze, Carl Philipp ^a   Feuchtinger, Tobias ^a   Scheel Walter, Hans Gerhard ^a   Lang, Peter ^a   Hildenbrand, Sibylle ^a   Gessler, Peter ^b   Handgretinger, Rupert ^c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Cardiology and Internal Intensive Medicine   (Germany)

^c Hospital of Constance ^*

Author keywords

acute promyelocytic leukemia (APL); arsenic trioxide (ATO); childhood

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; PREDNISONE; RETINOIC ACID RECEPTOR ALPHA; TIOGUANINE; VINCRISTINE;

ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; CHILD; CHILDHOOD CANCER; FEVER; FOLLOW UP; GRANULOCYTOPENIA; HEART ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOCYTOSIS; MALE; MULTIPLE CYCLE TREATMENT; PROMYELOCYTIC LEUKEMIA; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SIDE EFFECT; SPLENOMEGALY; TREATMENT OUTCOME;

ARSENICALS; CHILD; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; OXIDES; RECURRENCE; REMISSION INDUCTION; TIME FACTORS;

EID: 79955566111     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2010.542557     Document Type: Article

References (15)

1. Soignet SL, Maslak P, Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998;339:1341-1348. (Pubitemid 28509343)
2. Mantadakis E, Samonis G, Kalmanti M. A comprehensive review of acute promyelocytic leukemia in children. Acta Haematol. 2008;119:73-82. (Pubitemid 351606165)
3. George B, Mathews V, Poonkuzhali B, et al. Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience. Leukemia. 2004;18: 1587-1590. (Pubitemid 39386334)
4. Zhang L, Zhao H, Zhu X, et al. Retrospective analysis of 65Chinese childrenwith acute promyelocytic leukemia: a single center experience. Pediatr Blood Cancer. 2008;51:210-215. (Pubitemid 351874415)
5. Zhang XW, Yan XJ, Zhou ZR, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science. 2010;328:240-243.
6. Tallman MS, Andersen JW, SchifferCA, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337:1021-1028. (Pubitemid 27430519)
7. Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997;89:3354-3360.
8. Fox E, Razzouk BI, Widemann BC, et al. Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. Blood. 2008;111:566-573.
9. CreutzigU, ZimmermannM, Lehrnbecher T, et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acutemyeloid leukemia: results of AML-BFM98. J Clin Oncol. 2006;24:4499-4506. (Pubitemid 46646248)
10. Mathews V, George B, Lakshmi KM, et al. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood. 2006;107:2627-2632.
11. Au WY, Lie AK, Chim CS, et al. Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemia. Ann Oncol. 2003;14:752-757. (Pubitemid 36621776)
12. Thirugnanam R, George B, Chendamarai E, et al. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Biol Blood Marrow Transplant. 2009;15:1479-1484.
13. Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 2004;101:5328-5335. (Pubitemid 38481160)
14. Au WY, Kwong YL. Arsenic trioxide: safety issues and their management. Acta Pharmacol Sin. 2008;29:296-304.
15. Mukherjee SC, RahmanMM,ChowdhuryUK, et al.Neuropathy in arsenic toxicity fromgroundwater arsenic contamination inWest Bengal, India. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2003;38:165-183. (Pubitemid 36267801)